Differential diagnosis and management of focal ground-glass opacities

European Respiratory Journal

Volumn 33, Issue 4, 2009, Pages 821-827

  Infante, M ^a   Lutman, R F ^a   Imparato, S ^a   Di Rocco, M ^a   Ceresoli, G L ^a   Torri, V ^a   Morenghi, E ^a   Minuti, F ^a   Cavuto, S ^a   Bottoni, E ^a   Inzirillo, F ^a   Cariboni, U ^a   Errico, V ^a   Incarbone, M A ^a   Ferraroli, G ^a   Brambilla, G ^a   Alloisio, M ^a   Ravasi, G ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Antibiotics; Diagnostic procedures; High resolution computed tomography management; Pulmonary nodules; Transthoracic needle aspiration biopsy

Indexed keywords

ANTIBIOTIC AGENT; LEVOFLOXACIN;

AGED; ARTICLE; BENIGN GROUND GLASS OPACITY; BIOPSY; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; FOCAL GROUND GLASS OPACITY; FOCAL PULMONARY GROUND GLASS OPACITY; FOLLOW UP; HEMOPTYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOLOGY; HUMAN; LOBECTOMY; LUNG CANCER; LUNG DISEASE; MALE; MALIGNANT GROUND GLASS OPACITY; MEDICAL DECISION MAKING; PERCUTANEOUS BIOPSY; PNEUMOTHORAX; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TUMOR VOLUME; VALIDITY;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; ANTI-BACTERIAL AGENTS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 63849319215     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00047908     Document Type: Article

References (30)

1. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleishner Society: glossary of terms for thoracic imaging. Radiology 2008; 246: 697-722.
2. Collins J, Stern EJ. Ground-glass opacity at CT: the ABCs. AJR Am J Roentgenol 1997; 169: 355-367.
3. Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002; 178: 1053-1057.
4. Kushihashi T, Munechika H, Ri K, et al. Bronchioloalveolar adenoma of the lung: CT-pathologic correlation. Radiology 1994; 193: 789-793.
5. Jang HJ, Lee KS, Kwon OJ, Rhee CH, Shim YM, Han J. Bronchioloalveolar carcinoma: focal area of ground-glass attenuation at thin-section CT as an early sign. Radiology 1996; 199: 485-488.
6. Gandara DR, Aberle D, Lau D, et al. Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment. J Thorac Oncol 2006; 1: Suppl. 9, S20-S26.
7. Nakata M, Saeki H, Takata I, et al. Focal ground-glass opacity detected by low-dose helical CT. Chest 2002; 121: 1464-1467.
8. Kakinuma R, Ohmatsu H, Kaneko M, et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr 2004; 28: 17-23.
9. Takashima S, Maruyama Y, Hasegawa M, et al. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. AJR Am J Roentgenol 2003; 180: 817-826.
10. Kim HY, Shim YM, Lee KS, Han J, Yi CA, Kim YK. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology 2007; 245: 267-275.
11. Infante M, Lutman FR, Cavuto S, et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. LungCancer 2008; 59: 355-363.
12. Li F, Sone S, Abe H, MacMahon H, Doi K. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology 2004; 233: 793-798.
13. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005; 23: 3279-3287.
14. Nambu A, Araki T, Taguchi Y, et al. Focal area of ground-glass opacity and ground-glass opacity predominance on thin-section CT: discrimination between neoplastic and non-neoplastic lesions. Clin Radiol 2005; 60: 1006-1017.
15. Kim TJ, Lee JH, Lee CT, et al. Diagnostic accuracy of CT-guided core biopsy of ground-glass opacity pulmonary lesions. AJR Am J Roentgenol 2008; 190: 234-239.
16. Oh JY, Kwon SY, Yoon HI, et al. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. LungCancer 2007; 55: 67-73.
17. Ohtsuka T, Watanabe K, Kaji M, Naruke T, Suemasu K. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg 2006; 30: 160-163.
18. Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg 2002; 73: 386-392.
19. Nakata M, Sawada S, Yamashita M, et al. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. JThoracCardiovascSurg2005; 129: 1226-1231.
20. Asamura H, Suzuki K, Watanabe S, Matsuno Y, Maeshima A, Tsuchiya R. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg2003; 76: 1016-1022.
21. Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: a predictor of lymph node metastasis. J Thorac Cardiovasc Surg 2002; 124: 278-284.
22. Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg 2006; 81: 413-419.
23. Okada M, Nishio W, Sakamoto T, et al. Correlation between computed tomographic findings, bronchioloal-veolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. J Thorac Cardiovasc Surg 2004; 127: 857-861.
24. Ohde Y, Nagai K, Yoshida J, et al. The proportion of consolidation to ground-glass opacity on high resolution CT is a good predictor for distinguishing the population of non-invasive peripheral adenocarcinoma. Lung Cancer 2003; 42: 303-310.
25. Okada M, Tauchi S, Iwanaga K, et al. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. J Thorac Cardiovasc Surg 2007; 133: 1448-1454.
26. Watanabe S, Watanabe T, Arai K, Kasai T, Haratake J, Urayama H. Results of wedge resection for focal bronch-ioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann Thorac Surg 2002; 73: 1071-1075.
27. Nakamura H, Saji H, Ogata A, Saijo T, Okada S, Kato H. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer 2004; 44: 61-68.
28. Yamada S, Kohno T. Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter. Ann Thorac Surg 2004; 77: 1911-1915.
29. Mun M, Kohno T. Efficacy of thoracoscopic resection for multifocal bronchioloalveolar carcinoma showing pure ground-glass opacities of 20 mm or less in diameter. J Thorac Cardiovasc Surg 2007; 134: 877-882.
30. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 2006; 132: 769-775.